For information on a site near you, call 1-800-244-7668 Option "2" — Salt Lake City, Utah

For information on a site near you, call 1-800-244-7668 Option "2" is a clinical research site located in Salt Lake City, Utah, United States.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

For information on a site near you, call 1-800-244-7668 Option "2" has participated in 1 clinical trials.

Therapeutic areas: Cystic Fibrosis.

Sponsors: Novartis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Salt Lake City

Browse all research sites in Utah · View every site in Salt Lake City

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for For information on a site near you, call 1-800-244-7668 Option "2"?

For information on a site near you, call 1-800-244-7668 Option "2" has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has For information on a site near you, call 1-800-244-7668 Option "2" conducted?

For information on a site near you, call 1-800-244-7668 Option "2" has 1 clinical trials on record. Their work covers Cystic Fibrosis.

Is For information on a site near you, call 1-800-244-7668 Option "2" accredited by Crixeo Clinical Trials?

For information on a site near you, call 1-800-244-7668 Option "2" has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about For information on a site near you, call 1-800-244-7668 Option "2"?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.